AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ARTRYA LTD

0.630

-0.005-0.79%

Volume:23.75K

Turnover:14.96K

Market Cap:71.04M

PE:-3.47

High:0.635

Open:0.635

Low:0.625

Close:0.635

Loading ...

Overview Company News Filings

Artrya Obtains 36-Month Contract with Lumus Imaging for Salix Coronary Anatomy Platform; Shares Up 3%

MT Newswires Live

BRIEF-Artrya Secures Contract With Lumus Imaging For Use Of Salix Coronary Anatomy

Artrya Ltd - Secures Contract With Lumus Imaging for Use of Salix Coronary Anatomy

THOMSON REUTERS

BUZZ-Australia's Artrya climbs as FDA clears Salix for US sale

BRIEF-Artrya Secures FDA Clearance For Salix Coronary Anatomy

Artrya pops +11% on yet another FDA approval for an Aussie biotech

The Market Herald

Artrya Ltd - Secures FDA Clearance for Salix Coronary Anatomy

THOMSON REUTERS

Artrya Responds to US Drug Watchdog's Queries for its Coronary Anatomy Product

MT Newswires Live

BRIEF-Artrya Reports HY Loss From Ordinary Activities After Tax Attributable A$7.4 Mln

BUZZ-Australia's Artrya slips most in over 2 weeks on discounted placement

BRIEF-Artrya Announces A$15 Million Placement

Artrya Ltd-Proposed Issue of Securities - Aya

THOMSON REUTERS

Artrya Ltd - a$15 Mln Placement at a$0.73 per Share

THOMSON REUTERS

BRIEF-Artrya Secures Multi-Year Contract With Sonic Healthcare

Artrya Signs Commercial Contract with Sonic Healthcare for Coronary Artery Disease Assessment Platform

MT Newswires Live

Artrya Ltd - Contract for Use of Salix Coronary Anatomy Platform

THOMSON REUTERS

ASX Alert-Aya Secures Multi-Year Contract With Sonic Healthcare-Aya.ax

THOMSON REUTERS

Artrya Ltd - Artrya Secures Multi-Year Commercial Contract With Sonic Healthcare Australia

THOMSON REUTERS

BRIEF-Artrya Ltd Seeks Trading Halt

5 ASX artificial intelligence (AI) shares to watch in 2025

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AYA.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AYA.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AYA.AU\",,,,,undefined,":{"symbol":"AYA.AU","market":"AU","secType":"STK","nameCN":"ARTRYA LTD","latestPrice":0.63,"timestamp":1745895226687,"preClose":0.635,"halted":0,"volume":23745,"delay":0,"nameEN":"ARTRYA LTD","floatShares":75432883,"shares":112755509,"eps":-0.181711,"marketStatus":"Trading","change":-0.005,"latestTime":"04-29 14:10:13 AEST","open":0.635,"high":0.635,"low":0.625,"amount":14956,"amplitude":0.015748,"askPrice":0.635,"askSize":6270,"bidPrice":0.625,"bidSize":542,"shortable":3,"etf":0,"ttmEps":-0.181711,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745906400000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.635,"openAndCloseTimeList":[[1745884800000,1745906400000]],"volumeRatio":0.142818,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AYA.AU\",,,,,undefined,":{"symbol":"AYA.AU","floatShares":75432883,"roa":"-43.33%","roe":"-75.75%","lyrEps":-0.178019,"volumeRatio":0.142818,"shares":112755509,"dividePrice":0,"high":0.635,"amplitude":0.015748,"preClose":0.635,"low":0.625,"week52Low":0.2,"pbRate":"4.84","psRate":"5464.31","week52High":1.04,"institutionHeld":0,"latestPrice":0.63,"committee":-0.840869,"eps":-0.181711,"divideRate":0,"volume":23745,"delay":0,"ttmEps":-0.181711,"open":0.635,"prevYearClose":0.53,"prevWeekClose":0.625,"prevMonthClose":0.75,"prevQuarterClose":0.75,"fiveDayClose":0.655,"twentyDayClose":0.8,"sixtyDayClose":0.9},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AYA.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524139269","title":"Artrya Obtains 36-Month Contract with Lumus Imaging for Salix Coronary Anatomy Platform; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2524139269","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524139269?lang=en_us&edition=fundamental","pubTime":"2025-04-01 12:22","pubTimestamp":1743481363,"startTime":"0","endTime":"0","summary":"Artrya  won a 36-month commercial contract with Lumus Imaging for the use of the Salix Coronary Anatomy platform, according to a Tuesday filing with the Australian bourse.Salix is designed to detect critical markers, including high-risk plaque, from CT coronary angiogram scans generated by a photon-counting CT scanner, per the filing.The contract is expected to bring in revenue through a software-as-a-service subscription model, the filing stated.Artrya's shares were up 3% in recent trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7094","AYA.AU"],"gpt_icon":0},{"id":"2524990660","title":"BRIEF-Artrya Secures Contract With Lumus Imaging For Use Of Salix Coronary Anatomy","url":"https://stock-news.laohu8.com/highlight/detail?id=2524990660","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524990660?lang=en_us&edition=fundamental","pubTime":"2025-04-01 06:35","pubTimestamp":1743460536,"startTime":"0","endTime":"0","summary":"BRIEF-Artrya Secures Contract With Lumus Imaging For Use Of Salix Coronary AnatomyApril 1 (Reuters) - Artrya Ltd AYA.AX:SECURES CONTRACT WITH LUMUS IMAGING FOR USE OF SALIX CORONARY ANATOMYFurther company coverage: AYA.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE1MF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AYA.AU","BK7094"],"gpt_icon":0},{"id":"2524190667","title":"Artrya Ltd - Secures Contract With Lumus Imaging for Use of Salix Coronary Anatomy","url":"https://stock-news.laohu8.com/highlight/detail?id=2524190667","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524190667?lang=en_us&edition=fundamental","pubTime":"2025-04-01 06:34","pubTimestamp":1743460468,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE1MF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AYA.AU","BK7094"],"gpt_icon":0},{"id":"2522252569","title":"BUZZ-Australia's Artrya climbs as FDA clears Salix for US sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2522252569","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522252569?lang=en_us&edition=fundamental","pubTime":"2025-03-28 10:04","pubTimestamp":1743127491,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Artrya climbs as FDA clears Salix for US sale** Shares of medical technology co Artrya AYA.AX rise 9.4% to A$0.875** Stock hits its highest level since January 20** Co secures U.S. Food and Drug Administration  clearance for commercial sale of Salix Coronary Anatomy in the United States** Salix is the first point of care approach for assessing coronary artery disease, says co** About 1.9 million shares change hands, 9.7 times the 30-day average volume of shares** Stock up 50.9% this year, as of last close  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nL6N3QB02U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","AYA.AU"],"gpt_icon":0},{"id":"2522563381","title":"BRIEF-Artrya Secures FDA Clearance For Salix Coronary Anatomy","url":"https://stock-news.laohu8.com/highlight/detail?id=2522563381","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522563381?lang=en_us&edition=fundamental","pubTime":"2025-03-28 09:14","pubTimestamp":1743124485,"startTime":"0","endTime":"0","summary":"BRIEF-Artrya Secures FDA Clearance For Salix Coronary AnatomyMarch 28 (Reuters) - Artrya Ltd AYA.AX:SECURES FDA CLEARANCE FOR SALIX CORONARY ANATOMYFurther company coverage: AYA.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nFWN3QA1DQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","AYA.AU"],"gpt_icon":0},{"id":"2522756550","title":"Artrya pops +11% on yet another FDA approval for an Aussie biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2522756550","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522756550?lang=en_us&edition=fundamental","pubTime":"2025-03-28 08:50","pubTimestamp":1743123000,"startTime":"0","endTime":"0","summary":"Artrya  is the latest Aussie biotech stock to score an FDA approval and consequent rewarding share price jump from traders and investors.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.Being approved is Artrya’s coronary imaging software platform ‘Salix’, called Salix Coronary Anatomy  in full. Not to overstate the obvious, but we’re talking about an ‘AI activated’  computer program – not a drug.According to Artrya, Salix is a breakthrough in the assessment of coronary artery disease – the first in 50 years. This statement is hard to fact-check, if it’s checkable at all.Those gains might have already been priced in an FDA approval. But for now, the company is keen to see SCA launch across a series of U.S. hospitals.The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and con","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/artrya-pops-11-on-yet-another-fda-approval-for-an-aussie-biotech-2025-03-28/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7094","SCA","AYA.AU"],"gpt_icon":0},{"id":"2522147555","title":"Artrya Ltd - Secures FDA Clearance for Salix Coronary Anatomy","url":"https://stock-news.laohu8.com/highlight/detail?id=2522147555","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522147555?lang=en_us&edition=fundamental","pubTime":"2025-03-28 06:39","pubTimestamp":1743115149,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nFWN3QA1DQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7094","AYA.AU"],"gpt_icon":0},{"id":"2514395766","title":"Artrya Responds to US Drug Watchdog's Queries for its Coronary Anatomy Product","url":"https://stock-news.laohu8.com/highlight/detail?id=2514395766","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514395766?lang=en_us&edition=fundamental","pubTime":"2025-02-28 12:41","pubTimestamp":1740717701,"startTime":"0","endTime":"0","summary":"Artrya  submitted its response to the US Food and Drug Administration's queries about its regulatory approval application for its Salix coronary anatomy product, according to a Friday Australian bourse filing.The technological product uses deep-learning algorithms to predictively diagnose potential acute coronary events, the company informed in an earlier filing.The company did not specify the nature of the queries.The company's shares rose 2% in recent Friday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7094","AYA.AU"],"gpt_icon":0},{"id":"2514308948","title":"BRIEF-Artrya Reports HY Loss From Ordinary Activities After Tax Attributable A$7.4 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2514308948","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514308948?lang=en_us&edition=fundamental","pubTime":"2025-02-25 09:28","pubTimestamp":1740446897,"startTime":"0","endTime":"0","summary":"BRIEF-Artrya Reports HY Loss From Ordinary Activities After Tax Attributable A$7.4 MlnFeb 25 (Reuters) - Artrya Ltd AYA.AX:HY LOSS FROM ORDINARY ACTIVITIES AFTER TAX ATTRIBUTABLE A$7.4 MILLIONFurther company coverage: AYA.AX ((Reuters.Briefs@thomsonreuters.com;;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nFWN3PF23O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","AYA.AU"],"gpt_icon":0},{"id":"2511681685","title":"BUZZ-Australia's Artrya slips most in over 2 weeks on discounted placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2511681685","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511681685?lang=en_us&edition=fundamental","pubTime":"2025-02-14 09:54","pubTimestamp":1739498071,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Artrya slips most in over 2 weeks on discounted placement** Shares of Artrya AYA.AX fall 3.5% to A$0.83** Stock marks its worst intraday drop since January 29** The medtech co says it has received commitments to raise A$15 million  via share placement at an issue price of A$0.73 apiece ** Issue price represents a discount of 17.8%, as of the stock's last close** Says placement proceeds will be used to accelerate commercial adoption of its Salix software in new U.S. hospitals** Stock surged 70.8% in January  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250214:nL4N3P506K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","AYA.AU","BK0251","688581"],"gpt_icon":0},{"id":"2511827683","title":"BRIEF-Artrya Announces A$15 Million Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2511827683","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511827683?lang=en_us&edition=fundamental","pubTime":"2025-02-14 09:38","pubTimestamp":1739497086,"startTime":"0","endTime":"0","summary":"BRIEF-Artrya Announces A$15 Million PlacementFeb 14 (Reuters) - Artrya Ltd AYA.AX:A$15 MILLION PLACEMENT AT A$0.73 PER SHAREFurther company coverage: AYA.AX ((Reuters.Briefs@thomsonreuters.com;;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250214:nFWN3P423P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AYA.AU","BK7094"],"gpt_icon":0},{"id":"2511598505","title":"Artrya Ltd-Proposed Issue of Securities - Aya","url":"https://stock-news.laohu8.com/highlight/detail?id=2511598505","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511598505?lang=en_us&edition=fundamental","pubTime":"2025-02-14 06:20","pubTimestamp":1739485215,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250213:nTUEM0LKS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7094","AYA.AU"],"gpt_icon":0},{"id":"2511505330","title":"Artrya Ltd -  a$15 Mln Placement at a$0.73 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2511505330","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511505330?lang=en_us&edition=fundamental","pubTime":"2025-02-14 06:19","pubTimestamp":1739485158,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250213:nFWN3P423P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AYA.AU","BK7094"],"gpt_icon":0},{"id":"2510098314","title":"BRIEF-Artrya Secures Multi-Year Contract With Sonic Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2510098314","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510098314?lang=en_us&edition=fundamental","pubTime":"2025-02-12 14:04","pubTimestamp":1739340290,"startTime":"0","endTime":"0","summary":"BRIEF-Artrya Secures Multi-Year Contract With Sonic HealthcareFeb 12 (Reuters) - Artrya Ltd AYA.AX:AYA SECURES MULTI-YEAR CONTRACT WITH SONIC HEALTHCARECONTRACT FOR USE OF SALIX CORONARY ANATOMY PLATFORMFurther company coverage: AYA.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nFWN3P21M7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AYA.AU","SHL.AU","BK7124","BK7094"],"gpt_icon":0},{"id":"2510315968","title":"Artrya Signs Commercial Contract with Sonic Healthcare for Coronary Artery Disease Assessment Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2510315968","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510315968?lang=en_us&edition=fundamental","pubTime":"2025-02-12 12:35","pubTimestamp":1739334958,"startTime":"0","endTime":"0","summary":"Artrya  secured a three-year commercial agreement with Sonic Healthcare's  radiology division for the use of Salix Coronary Anatomy platform for coronary artery disease assessment at the point of care, according to a Wednesday Australian bourse filing.The contract will generate revenue through a software-as-a-service subscription model and the first revenue is expected in the fiscal fourth quarter, the filing said.Salix will be integrated into all Sonic Healthcare radiology centers that perform coronary computed tomography angiography scans for coronary heart disease detection, per the filing.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7124","BK4137","HCSG","BK7094","AYA.AU","SHL.AU"],"gpt_icon":0},{"id":"2510903743","title":"Artrya Ltd -  Contract for Use of Salix Coronary Anatomy Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2510903743","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510903743?lang=en_us&edition=fundamental","pubTime":"2025-02-12 11:37","pubTimestamp":1739331431,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nFWN3P21M7:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7094","AYA.AU"],"gpt_icon":0},{"id":"2510390325","title":"ASX Alert-Aya Secures Multi-Year Contract With Sonic Healthcare-Aya.ax","url":"https://stock-news.laohu8.com/highlight/detail?id=2510390325","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510390325?lang=en_us&edition=fundamental","pubTime":"2025-02-12 11:37","pubTimestamp":1739331431,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nFWN3P21M7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7094","AYA.AU"],"gpt_icon":0},{"id":"2510326390","title":"Artrya Ltd - Artrya Secures Multi-Year Commercial Contract With Sonic Healthcare Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2510326390","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510326390?lang=en_us&edition=fundamental","pubTime":"2025-02-12 11:37","pubTimestamp":1739331431,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nFWN3P21M7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7094","AYA.AU"],"gpt_icon":0},{"id":"2510336551","title":"BRIEF-Artrya Ltd Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2510336551","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510336551?lang=en_us&edition=fundamental","pubTime":"2025-02-12 06:25","pubTimestamp":1739312717,"startTime":"0","endTime":"0","summary":"BRIEF-Artrya Ltd Seeks Trading HaltFeb 12 (Reuters) - Artrya Ltd AYA.AX:ARTRYA LTD - SEEKS TRADING HALT PENDING ANNOUNCEMENT ON LICENSE AGREEMENT AND CAPITAL RAISINGFurther company coverage: AYA.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250211:nFWN3P21RY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AYA.AU","BK7094"],"gpt_icon":0},{"id":"2503565680","title":"5 ASX artificial intelligence (AI) shares to watch in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2503565680","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503565680?lang=en_us&edition=fundamental","pubTime":"2025-01-15 06:15","pubTimestamp":1736892952,"startTime":"0","endTime":"0","summary":"If you followed artificial intelligence (AI) or technology stock market news in 2024, you probably heard about the monster gains delivered by US chip maker Nvidia Corp (NASDAQ: NVDA). Many investors w","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/01/15/5-asx-artificial-intelligence-ai-shares-to-watch-in-2025/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["NVDX","LU2023250330.USD","LU0048584097.USD","LU0154236417.USD","LU1674673691.USD","LU0061475181.USD","LU1261432733.SGD","APX.AU","LU0823421416.USD","LU1951200564.SGD","LU2413666426.HKD","LU0466842654.USD","NVDA","NVDS","LU2125909916.SGD","LU2357125470.USD","LU1914381329.SGD","LU0345768153.USD","AYA.AU","LU2756315664.SGD","NVD","NVDY","NVD3.UK","SNVD.UK","NVDD","LU2065170008.USD","360.AU","LU2063271972.USD","LU0965508806.USD","LU2065169927.USD","LU1868836914.USD","NVDU","2NVD.UK","LU0354030511.USD","3NVD.UK","IE00BD6J9T35.USD","IE00BQXX3F31.USD","NXT.AU","IE00BQXX3D17.EUR","NVIW.SI","NVDS.UK","LU0348723411.USD","LIF","NVD2.UK","LU0868494708.USD","LU1804176565.USD","WBT.AU","IE00BKPKM429.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":26,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AYA.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AYA.AU\",market:\"AU\",,,undefined,":[]}}